Real-world evidence of the antifibrotic nintedanib in rheumatoid arthritis-interstitial lung disease. National multicenter study of 74 patients.
Atienza-Mateo B, Serrano-Combarro A, Loarce Martos J, Vegas-Revenga N, Martín López M, Castañeda S, Melero-González RB, Mena Vázquez N, Carrasco-Cubero C, Díez Morrondo C, Castro Corredor D, Vázquez Rodríguez TR, García Valle A, Bonilla G, Rodríguez López M, Braña Abascal I, Rojas Herrera SM, Sarmiento-Monroy JC, Andújar Brazal P, Ferrer D, Ferraz-Amaro I, Blanco R; Spanish Collaborative Group of Antifibrotics in Interstitial Lung Disease Associated with Rheumatoid Arthritis.
Atienza-Mateo B, et al.
Semin Arthritis Rheum. 2025 Jun;72:152710. doi: 10.1016/j.semarthrit.2025.152710. Epub 2025 Mar 14.
Semin Arthritis Rheum. 2025.
PMID: 40117729